Novozymes is the world leader in bioinnovation. Our business is industrial enzymes, microorganisms, and biopharmaceutical ingredients. We provide business-to-business biological solutions used in the production of numerous products such as biofuel, detergents, feed, and crops.
In 2008, we achieved revenue of DKK 8,146 million, based on more than 700 products sold in 130 countries. Up to 14% of our revenue is spent on research and development, and we currently have more than 6,000 patents in place, which is evidence of what is possible when nature and technology join forces. We have over 5,000 employees globally.
We use biotechnology to challenge traditional thinking in order to find sustainable solutions. In other words, we ask the world to “Rethink Tomorrow.” Our solutions are based on a unique technology platform that provides a wealth of opportunities for the world’s industries. Gene technology, microbial techniques, and fermentation technology are some of the biotechnological tools on which we base our business.
Using this technology platform, we work with customers across a broad range of industries, and through this cooperation we create tomorrow’s industrial biosolutions to improve our customers’ business and the use of our planet’s resources.
Sustainability is an integral part of our business, and we enable our customers to be more sustainable by optimizing the use of raw materials and energy, thereby reducing the environmental impact of their operations. Worldwide application of our bioinnovation has enabled reductions in CO2 emissions of approximately 28 million tons in 2008 alone.
Doing business based on values
The Novozymes Touch states how we want to do business. We believe that decency and responsibility in business are about being aware of and acting upon important stakeholder relations, as well as being committed to international agreements and universal values: